Alternatives · ranked by WeighScore
Alternatives to NextMeds
NextMeds grades C (66.3/100), #212 of 544 on our scorecard. Here are the other providers we've graded on the same six dimensions — ranked by WeighScore, highest first.
You're comparing against
NextMeds →Our top-graded alternative
CoreAge Rx leads the full scorecard.
Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
More alternatives, ranked
Mid-value both-molecule pricing ($130/$163), verified, and nationwide.
Tight both-molecule spread ($133/$166), verified and nationwide.
Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.
Cheap semaglutide ($119) but a steeper tirzepatide step-up ($229); verified, nationwide.
Low-ish both-molecule pricing ($117/$196), nationwide — but unverified.
The 6 above are the closest matches to NextMeds on the WeighScore. Every provider we grade — all 544 of them — is scored on the same six factors: browse every graded provider.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.